Boeringer Ingelheim Ltd and IBM Canada plan to explore the use of blockchain technology in clinical trials. This marks the first time that blockchain technology will be used in a clinical trial setting in Canada. The alliance aims to improve the quality of clinical trial processes and record keeping. (Contract Pharma)
Clinical research industry’s 3 wishes for 2019
What might the clinical research industry wish for in 2019 to improve their ability to bring new products to market? Innovation in patient recruitment; blockchain to improve clinical research data storage; and a greater variety of eClinical platforms to meet the needs of researchers in different areas. (medrio)